Loading...
Loading...
India's plasma imports from SINGAPORE total $70.4K across 241 shipments from 15 foreign suppliers. SYSMEX ASIA PACIFIC PTE LTD leads with $26.8K in import value; the top 5 suppliers together control 81.4% of this origin. Leading Indian buyers include SYSMEX INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for plasma โ a diversified sourcing base with multiple active suppliers from SINGAPORE.

SYSMEX ASIA PACIFIC PTE LTD is the leading Plasma supplier from SINGAPORE to India, with import value of $26.8K across 9 shipments. The top 5 suppliers โ SYSMEX ASIA PACIFIC PTE LTD, LABCORP DEVELOPMENT (ASIA) PTE LTD, M/S. LABCORP DEVELOPMENT (ASIA) PTE, CORDLIFE GROUP LTD, ICON LABORATORY SERVICES โ collectively account for 81.4% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SYSMEX ASIA PACIFIC PTE LTD | $26.8K | 9 | 38.1% |
| 2 | LABCORP DEVELOPMENT (ASIA) PTE LTD | $13.4K | 49 | 19.1% |
| 3 | M/S. LABCORP DEVELOPMENT (ASIA) PTE | $6.6K | 2 | 9.4% |
| 4 | CORDLIFE GROUP LTD | $5.2K | 27 | 7.4% |
| 5 | ICON LABORATORY SERVICES | $5.2K | 38 | 7.4% |
| 6 | Q SQUARED SOLUTIONS PTE. LTD | $3.7K | 46 | 5.3% |
| 7 | Q SQUARED SOLUTIONS PTE LTD | $2.3K | 16 | 3.3% |
| 8 | LABCORP DEVELOPMENT ASIA PTE LTD | $2.2K | 10 | 3.1% |
| 9 | CORDLIFE GROUP LIMITED | $2.1K | 8 | 3.0% |
| 10 | Q SQUARED SOLUTIONS PTE. LTD. | $633 | 6 | 0.9% |
| 11 | Q SQUARED SOLUTIONS PTE LIMITED | $534 | 10 | 0.8% |
| 12 | LABCORP DEVELOPMENT (ASIA) PTE LIMITED | $380 | 2 | 0.5% |
| 13 | LABCORP DEVELOPMENT ASIA PTE LIMITED | $326 | 4 | 0.5% |
| 14 | Q SQUARED SOLUTIONS PTE LED | $299 | 3 | 0.4% |
| 15 | Q SQUARED SOLUTIONS PTE. LIMITED | $265 | 3 | 0.4% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SYSMEX INDIA PRIVATE LIMITED | $26.8K | 9 | 38.1% |
| 2 | VEEDA CLINICAL RESEARCH LIMITED | $26.3K | 153 | 37.4% |
| 3 | EUROFINS ADVINUS BIOPHARMA SERVICES INDIA PRIVATE | $6.6K | 2 | 9.4% |
| 4 | CORDLIFE SCIENCES INDIA PVT LTD | $4.8K | 25 | 6.8% |
| 5 | CORDLIFE SCIENCES INDIA PRIVATE LIMITED | $2.1K | 8 | 3.0% |
| 6 | VEEDA CLINICAL RESEARCH PRIVATE LIMITED | $1.1K | 18 | 1.6% |
| 7 | VEEDA CLINICAL RESEARCH PVT LTD | $939 | 9 | 1.3% |
| 8 | VEEDA CLINICAL RESEARCH PVT. LTD. | $654 | 5 | 0.9% |
| 9 | CORDLIFE SCIENCES INDIA PVT. LTD. | $419 | 2 | 0.6% |
| 10 | LAMBDA THERAPEUTIC RESEARCH LIMITED | $232 | 1 | 0.3% |
| 11 | ROCHE PRODUCTS (INDIA) PRIVATE LIMITED | $192 | 1 | 0.3% |
| 12 | SAI LIFE SCIENCES LIMITED | $46 | 4 | 0.1% |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $25 | 1 | 0.0% |
| 14 | PERFOMICS ANALYTICAL LABS LLP | $12 | 1 | 0.0% |
| 15 | ALTHEA DRF LIFESCIENCES LIMITED | $12 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Plasma suppliers from SINGAPORE to India include SYSMEX ASIA PACIFIC PTE LTD, LABCORP DEVELOPMENT (ASIA) PTE LTD, M/S. LABCORP DEVELOPMENT (ASIA) PTE. The leading supplier is SYSMEX ASIA PACIFIC PTE LTD with import value of $26.8K USD across 9 shipments. India imported Plasma worth $70.4K USD from SINGAPORE in total across 241 shipments.
India imported Plasma worth $70.4K USD from SINGAPORE across 241 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Plasma sourced from SINGAPORE include SYSMEX INDIA PRIVATE LIMITED, VEEDA CLINICAL RESEARCH LIMITED, EUROFINS ADVINUS BIOPHARMA SERVICES INDIA PRIVATE. The largest buyer is SYSMEX INDIA PRIVATE LIMITED with $26.8K in imports across 9 shipments.
The total value of Plasma imports from SINGAPORE to India is $70.4K USD, across 241 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
241 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists